JTK-109
JTK-109 is a small molecule inhibitor targeting the hepatitis C virus NS5B RNA-dependent RNA polymerase. It demonstrates inhibitory activity against HCV genotypes 1b and 3a in subgenomic replicon assays and against recombinant enzymes. This compound is a valuable tool for antiviral research in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
480462-62-2
Product Name Alternative
HCV Protease, HCVProtease, JTK109, JTK-109, JTK 109, NS5B polymerase
Field of Research
Infectious Disease & Virology, Protein Biochemistry
Purity
98.48% (May vary between batches)
Solubility
DMSO:6.39 mg/mL (10.01 mM)
Smiles
FC1=C (C=2N (C=3C (N2) =CC (C (O) =O) =CC3) C4CCCCC4) C=CC (OCC5=C (C=CC (=C5) N6C (=O) CCC6) C7=CC=C (Cl) C=C7) =C1
Molecular Formula
C37H33ClFN3O4
Molecular Weight
638.13
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP35035_P050-HRP 100 µL
Accn2 Antibody - N-terminal region : HRP (ARP35035_P050-HRP)
Sign In for Pricing
View Details MBS1137307 Inquire
Recombinant Mesocricetus auratus Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (DAD1)
Sign In for Pricing
View Details S1014-55C2-ML405 100 µL
SMAD4 (T277) (Mothers Against Decapentaplegic Homolog 4, SMAD 4, Mothers Against DPP Homolog 4, Deletion Target In Pancreatic Carcinoma 4, MAD Homolog 4, SMAD Family Member 4, hSMAD4, DPC4, MADH4) (MaxLight 405) discontinued
Sign In for Pricing
View Details